Israel - English - Ministry of Health

taro international ltd, israel - esomeprazole - tablets - esomeprazole 40 mg - esomeprazole - esomeprazole - nexium tablets are indicated in adults for:gastroesophageal reflux disease (gerd)- treatment of erosive reflux esophagitis- long-term management of patients with healed esophagitis to prevent relapse- symptomatic treatment of gastroesophageal reflux disease (gerd)in combination with an appropriate antibacterial therapeutic regimen for the eradication of helicobacter pylori and:- healing of helicobacter pylori associated duodenal ulcer and- prevention of relapse of peptic ulcers in patients with helicobacter pylori associated ulcers.patients requiring nsaid therapy- healing of gastric ulcers associated with nsaid therapy. - prevention of gastric and duodenal ulcers associated with nsaid therapy in patients at risk.prolonged treatment after i.v. induced prevention of rebleeding of peptic ulcers.nexium 40 mg tablets are indicated in adolescents from the age of 12 years for;gastroesophageal reflux disease (gerd)- treatment of erosive reflux esophagitis

Israel - English - Ministry of Health

astrazeneca (israel) ltd - esomeprazole - tablets - esomeprazole 40 mg - esomeprazole - esomeprazole - nexium tablets are indicated in adults for:gastroesophageal reflux disease (gerd)- treatment of erosive reflux esophagitis- long-term management of patients with healed esophagitis to prevent relapse- symptomatic treatment of gastroesophageal reflux disease (gerd)in combination with an appropriate antibacterial therapeutic regimen for the eradication of helicobacter pylori and:- healing of helicobacter pylori associated duodenal ulcer and- prevention of relapse of peptic ulcers in patients with helicobacter pylori associated ulcers.patients requiring nsaid therapy- healing of gastric ulcers associated with nsaid therapy. - prevention of gastric and duodenal ulcers associated with nsaid therapy in patients at risk.prolonged treatment after i.v. induced prevention of rebleeding of peptic ulcers.nexium 40 mg tablets are indicated in adolescents from the age of 12 years for;gastroesophageal reflux disease (gerd)- treatment of erosive reflux esophagitis

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - pseudoephedrine hydrochloride, quantity: 30 mg; dextromethorphan hydrobromide monohydrate, quantity: 15 mg; paracetamol, quantity: 500 mg - tablet, film coated - excipient ingredients: carnauba wax; purified water; povidone; magnesium stearate; hydrogenated vegetable oil; croscarmellose sodium; microcrystalline cellulose; pregelatinised maize starch; sodium starch glycollate; titanium dioxide; hypromellose; iron oxide yellow; macrogol 400 - provides temporary relief of nagging cough and discomfort associated with cold and flu: relieves blocked noses, dries runny noses, provides temporary relief of cough and headache, relieves body aches and pains, reduces fever.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - methyldopa sesquihydrate, quantity: 283 mg (equivalent: methyldopa, qty 250 mg) - tablet, film coated - excipient ingredients: guar gum; titanium dioxide; purified talc; sodium calcium edetate; iron oxide red; citric acid; quinoline yellow aluminium lake; hypromellose; ethylcellulose; propylene glycol; carnauba wax; magnesium stearate; powdered cellulose; colloidal anhydrous silica; citric acid monohydrate - hypertension (mild, moderate to severe).

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - pazopanib hydrochloride, quantity: 216.7 mg - tablet, film coated - excipient ingredients: povidone; magnesium stearate; sodium starch glycollate; microcrystalline cellulose; titanium dioxide; hypromellose; polysorbate 80; iron oxide red; macrogol 400 - votrient is indicated for the treatment of advanced and/or metastatic renal cell carcinoma (rcc). votrient is indicated for the treatment of patients with advanced (unresectable and/or metastatic) soft tissue sarcoma (sts) in patients who, unless otherwise contraindicated, have received prior chemotherapy including an anthracycline treatment. the phase iii trial population excluded patients with gastrointestinal stromal tumour (gist) or adipocytic soft tissue sarcoma.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - pazopanib hydrochloride, quantity: 433.4 mg - tablet, film coated - excipient ingredients: sodium starch glycollate; magnesium stearate; povidone; microcrystalline cellulose; titanium dioxide; hypromellose; polysorbate 80; macrogol 400 - votrient is indicated for the treatment of advanced and/or metastatic renal cell carcinoma (rcc). votrient is indicated for the treatment of patients with advanced (unresectable and/or metastatic) soft tissue sarcoma (sts) in patients who, unless otherwise contraindicated, have received prior chemotherapy including an anthracycline treatment. the phase iii trial population excluded patients with gastrointestinal stromal tumour (gist) or adipocytic soft tissue sarcoma.

Australia - English - Department of Health (Therapeutic Goods Administration)

medical diagnostics australasia pty ltd - urea(13c), quantity: 50 mg - tablet, uncoated - excipient ingredients: magnesium stearate; colloidal anhydrous silica; croscarmellose sodium; purified talc; microcrystalline cellulose; citric acid - this medicinal product is for diagnostic use only. diabact ubt is for in vivo diagnosis of gastroduodenal helicobacter pylori infection.

Australia - English - Department of Health (Therapeutic Goods Administration)

medical diagnostics australasia pty ltd - urea(13c), quantity: 50 mg - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; microcrystalline cellulose; citric acid; purified talc; croscarmellose sodium; magnesium stearate - this medicinal product is for diagnostic use only. diabact ubt is for in vivo diagnosis of gastroduodenal helicobacter pylori infection.

Australia - English - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - zolpidem tartrate, quantity: 10 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; sodium starch glycollate type a; hypromellose; magnesium stearate; titanium dioxide; macrogol 400 - zolpidem tartrate is indicated for the short term treatment of insomnia in adults (see dosage and administration).

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - bromhexine hydrochloride, quantity: 8 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; magnesium stearate; maize starch - for use as a mucolytic to break down mucus and help clear the chest in conditions accompanied by excessive mucus secretions such as in the common cold, influenza, infections of the respiratory tract or in other conditions where excess mucus is produced.